109 Targeted therapies, including AXL or TAM-family receptor inhibition, are currently undergoing early-phase clinical evaluation and remain largely supported by preclinical evidence
For the most current FDA position, readers should consult FDA.gov directly

Ingredients: Water, Centella Asiatica Extract (29.2%), Butylene Glycol, Propanediol, Niacinamide (20,000ppm), Glycerin, Diethoxyethyl Succinate, Panthenol, Sodium Hyaluronate, Allantoin, Glutathione (1,000ppm), Sodium Polyacryloyldimethyl Taurate, Glyceryl Acrylate/Acrylic Acid Copolymer, Nelumbo Nucifera Extract, Artemisia Annua Extract, Oryza Sativa (Rice) Extract, Saccharomyces Ferment, Solanum Melongena (Eggplant) Fruit Extract, Melaleuca Alternifolia (Tea Tree) Leaf Extract, Hydrolyzed Collagen, Squalane, Beta-Glucan, Dipropylene Glycol, Hippophae Rhamnoides Fruit Extract, Adenosine, Madecassic Acid, Asiaticoside, Asiatic Acid, Caprylic/Capric Triglyceride, Hydrogenated Lecithin, Glyceryl Stearate, Cholesterol, Styrene/Acrylates Copolymer, Cellulose Gum, Xanthan Gum, Inulin, Cellulose, Glucose, Fructose, Citric Acid, Disodium EDTA, Hydroxyacetophenone, 1,2-Hexanediol, Ethylhexylglycerin, Dipotassium Glycyrrhizate, Sodium Citrate

Heres the formal language from the guidelines, For people with type 2 diabetes and chronic kidney disease with albuminuria treated with maximum tolerated doses of ACE inhibitor or angiotensin receptor blocker, the addition of finerenone is recommended to improve cardiovascular outcomes and reduce the risk of chronic kidney disease progression
Maintain usual hydration
- Chloride